Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Seizure Drug May Help in MS Eye Disease
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis.
Molecular analysis of interleukin-25 exons 1 and 2 and its serum levels in Iranian patients with multiple sclerosis.
The genetics of multiple sclerosis: review of current and emerging candidates.
New data presented at 29th ECTRIMS congress reinforce the clinical profile of investigational laquinimod on disease progression and inflammation in relapsing-remitting multiple sclerosis
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
Prolactin in multiple sclerosis.
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.
Application of laser radiation and magnetostimulation in therapy of patients with multiple sclerosis.
PDE4B as a microglia target to reduce neuroinflammation.
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values.
Early and Degressive Putamen Atrophy in Multiple Sclerosis.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Transcriptional expression of MBP in oligodendrocytes depends on functional syntaxin 4; a potential correlation with autocrine signalling.
The high cost of spasticity in multiple sclerosis to individuals and society.
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Multiple Sites of the Cleavage of 21- and 25-Mer Encephalytogenic Oligopeptides Corresponding to Human Myelin Basic Protein (MBP) by Specific Anti-MBP Antibodies from Patients with Systemic Lupus Erythematosus.
Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects.
Neuromyelitis optica and pregnancy.
Impact of simulated microgravity on oligodendrocyte development: implications for central nervous system repair.
Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
Case report: an orofacial pain patient with spots on the brain-multiple sclerosis versus central systemic lupus erythematosus.
Heligmosmoides polygyrus: EAE remission is correlated with different systemic cytokine profiles provoked by L4 and adult nematodes.
Pages
« first
‹ previous
…
323
324
325
326
327
328
329
330
331
…
next ›
last »